TITLE

Sarcomeric Genotyping in Hypertrophic Cardiomyopathy

AUTHOR(S)
Van Driest, Sara L.; Ommen, Steve R.; Tajik, A. Jamil; Gersh, Bernard J.; Acerman, Michael J.
PUB. DATE
April 2005
SOURCE
Mayo Clinic Proceedings;Apr2005, Vol. 80 Issue 4, p463
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
OBJECTIVE: To pool results from studies of patients with hyper-trophic cardiomyopathy (HCM) to elucidate important phenotypic differences among genotypes. MATERIAL AND METHODS: Data published from November 1998 through November 2004 were gathered and compared from unrelated study population genotyping studies from the Mayo Clinic (Rochester, Minn), Harvard Medical School (Boston, Mass), France, Germany, Sweden, Finland, and Spain. Standard statistical analysis techniques were used to pool and compare data across genotypes with respect to frequency of mutations, age at diagnosis, and degree of hypertrophy (left ventricular wail thickness). RESULTS: The French study population harbored the highest frequency of mutations (61%), followed by the Mayo Clinic (38%), Harvard Medical School (36%), and Swedish (30%) study populations. For every study population, mutations in myosin binding protein C (MYBPC3) were the most common cause of HCM. Patients with a family history of HCM had mutations more frequently than those without. This pooled analysis revealed no statistically significant differences in left ventricular wail thickness or in mean age at diagnosis across all genotypes. CONCLUSIONS: Differentiation of sarcomeric genotypes, such as MYBPC3-HCM and MYH7-HCM, is not possible on the basis of currently reported phenotypic data. A myriad of genetic and/or environmental modifiers in addition to the primary disease-causing genetic substrate must play an important role in determining a patient's particular phenotype.
ACCESSION #
16768643

 

Related Articles

  • Combined Heterozygous Plasminogen Deficiency and Factor V Leiden Defect in the Same Kindred. Sartori, Maria Teresa; Simioni, Paolo; Patrassi, Giovanni Maurizio; Theodoridis, Panagiotis; Tormene, Daniela; Girolami, Antonio // Clinical & Applied Thrombosis/Hemostasis;Jan2000, Vol. 6 Issue 1, p36 

    Combined plasminogen deficiency and resistance to activated protein C defect (factor V Leiden) have been described in a few families and associated with a variable occurrence of thrombotic events. Here we describe a new family with thrombophilia and the presence of hypoplasminogenemia and factor...

  • Hypertrophic Obstructive Cardiomyopathy, Bleeding History, and Acquired von Willebrand Syndrome: Response to Septal Myectomy. BLACKSHEAR, JOSEPH L.; SCHAFF, HARTZELL V.; OMMEN, STEVE R.; DONG CHEN; NICHOLS, WILLIAM L. // Mayo Clinic Proceedings;Mar2011, Vol. 86 Issue 3, p219 

    Bleeding with severe aortlc stenosis is linked to acquired von Wiliebrand syndrome and loss of high-molecular-weight multimers of von Willebrand factor. Valve replacement resolves bleeding tendency and loss of high-molecular-weight muitimers. We report outcomes In 5 patients with symptomatic...

  • Association of Congenital Afibrinogenemia and K-Dependent Protein C Deficiency--A Case Report. de Mania, Domenico; Regina, Guido; Giordano, Paola; del Vecchio, Giovanni Carlo; Altomare, Maria; Scheuini, Francesco // Angiology;Sep1993, Vol. 44 Issue 9, p745 

    The authors describe a rare case of congenital afibrinogenemia with concomitant K-dependent protein C deficit that was brought to our observation for ischemic lesions of the foot in association with fibrinogen concentrate infusions. These lesions can be attributed to the association of various...

  • The frequency of FV G1691A and PT G20210A mutations in an Albanian population. Avni Atay, A.; Tekin, Mustafa; Allajalebeu, Klodian; Eğin, Yonca; Akar, Nejat // Turkish Journal of Hematology;Sep2011, Vol. 28 Issue 3, p241 

    A letter to the editor is presented which is concerned with the frequency of FV G1691A and PT G20210A mutations in an Albanian population.

  • Cytoplasmic accumulation of TDP-43 in circulating lymphomonocytes of ALS patients with and without TARDBP mutations. De Marco, Giovanni; Lupino, Elisa; Calvo, Andrea; Moglia, Cristina; Buccinn�, Barbara; Grifoni, Silvia; Ramondetti, Cristina; Lomartire, Annarosa; Rinaudo, Maria Teresa; Piccinini, Marco; Giordana, Maria Teresa; Chi�, Adriano // Acta Neuropathologica;May2011, Vol. 121 Issue 5, p611 

    TDP-43, encoded by TARDBP, is a ubiquitously expressed, primarily nuclear protein. In recent years, TDP-43 has been identified as the major pathological protein in ALS due to its mislocalisation in the cytoplasm of motor neurons of patients with and without TARDBP mutations and expression in...

  • COAGULATION GENES AND PREGNANCY. Kovalenko, K. A.; Gutnikova, L. V.; Mashkina, E. V.; Shkurat, T. P. // Reproductive BioMedicine Online (Reproductive Healthcare Limited;Oct2010 S3 Supplemen, Vol. 20, pS11 

    Genetic factors are among the leading causes of pregnancy loss, especially in the early stages of the pregnancy. It is now established that the syndrome of fetal loss is caused not only by chromosomal abnormalities, but also gene mutations, as well as the presence of polymorphic alleles of genes...

  • Protein C -1641A/-1654C haplotype is associated with organ dysfunction and the fatal outcome of severe sepsis in Chinese Han population. Qi Xing Chen; Shui Jing Wu; Hai Hong Wang; Chen Lv; Bao Li Cheng; Guo Hao Xie; Xiang Ming Fang // Human Genetics;Apr2008, Vol. 123 Issue 3, p281 

    Activation of protein C plays an important role in modulating coagulation as well as inflammation during severe sepsis. The baseline of activated protein C level in patients with severe sepsis showed interindividual variability between survivors and nonsurvivors, and the decreased level of...

  • Polymorphisms in BRCA1, BRCA1-interacting genes and susceptibility of breast cancer in Chinese women. Xiang Huo; Cheng Lu; Xinen Huang; Zhibin Hu; Guangfu Jin; Hongxia Ma; Xuechen Wang; Jianwei Qin; Xinru Wang; Hongbing Shen; Jinhai Tang // Journal of Cancer Research & Clinical Oncology;Nov2009, Vol. 135 Issue 11, p1569 

    BRCA1-interacting protein C-terminal helicase 1 (BRIP1) and zinc finger protein 350 (ZNF350) work with BRCA1 in tumor suppression procedures. Low penetrance variants of these three genes may jointly affect individuals’ breast cancer susceptibility in general population. We focused on...

  • MOLECULAR PATHOPHYSIOLOGY OF THROMBOTIC STATES AND THEIR IMPACT TO LABORATORY DIAGNOSTICS. Slavik, Ludek; Krcova, Vera; Hlusi, Antonin; Prochazkova, Jana; Prochazka, Martin; Ulehlova, Jana; Indrak, Karel // Biomedical Papers of the Medical Faculty of Palacky University i;2009, Vol. 153 Issue 1, p19 

    Background: Molecular genetic methods were implemented in the detection of thrombophilic disorders in the 1990's with the discovery of coagulation inhibitors antithrombin III (AT III), protein C (PC) and S (PS). The discovery of the molecular cause of activated protein C (APC) resistance by...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics